DE69521275D1 - Pharmazeutische Zubereitungen enthaltend Cefaclor - Google Patents

Pharmazeutische Zubereitungen enthaltend Cefaclor

Info

Publication number
DE69521275D1
DE69521275D1 DE69521275T DE69521275T DE69521275D1 DE 69521275 D1 DE69521275 D1 DE 69521275D1 DE 69521275 T DE69521275 T DE 69521275T DE 69521275 T DE69521275 T DE 69521275T DE 69521275 D1 DE69521275 D1 DE 69521275D1
Authority
DE
Germany
Prior art keywords
cefaclor
pharmaceutical preparations
preparations containing
manufacture
dispersible tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69521275T
Other languages
English (en)
Other versions
DE69521275T2 (de
Inventor
Mendizabal Flavia Arce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly SA
Original Assignee
Lilly SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly SA filed Critical Lilly SA
Application granted granted Critical
Publication of DE69521275D1 publication Critical patent/DE69521275D1/de
Publication of DE69521275T2 publication Critical patent/DE69521275T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DE69521275T 1994-12-13 1995-07-17 Pharmazeutische Zubereitungen enthaltend Cefaclor Expired - Fee Related DE69521275T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09402530A ES2079327B1 (es) 1994-12-13 1994-12-13 Formulaciones farmaceuticas de cefaclor.

Publications (2)

Publication Number Publication Date
DE69521275D1 true DE69521275D1 (de) 2001-07-19
DE69521275T2 DE69521275T2 (de) 2001-10-31

Family

ID=8288235

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69521275T Expired - Fee Related DE69521275T2 (de) 1994-12-13 1995-07-17 Pharmazeutische Zubereitungen enthaltend Cefaclor
DE0716852T Pending DE716852T1 (de) 1994-12-13 1995-07-17 Pharmazeutische Zubereitungen enthaltend Cefaclor

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE0716852T Pending DE716852T1 (de) 1994-12-13 1995-07-17 Pharmazeutische Zubereitungen enthaltend Cefaclor

Country Status (32)

Country Link
US (1) US5861141A (de)
EP (3) EP0716852B1 (de)
JP (1) JPH08208484A (de)
KR (1) KR100350565B1 (de)
CN (1) CN1136852C (de)
AT (1) ATE201984T1 (de)
AU (1) AU702585B2 (de)
BR (1) BR9504573A (de)
CA (1) CA2158511A1 (de)
CO (1) CO4410176A1 (de)
CZ (1) CZ287248B6 (de)
DE (2) DE69521275T2 (de)
DK (1) DK0716852T3 (de)
ES (2) ES2079327B1 (de)
FI (1) FI953887A (de)
GR (2) GR960300062T1 (de)
HK (1) HK1012574A1 (de)
HU (1) HUT73792A (de)
IL (1) IL114642A (de)
MY (1) MY114687A (de)
NO (1) NO309925B1 (de)
NZ (1) NZ272611A (de)
PE (1) PE5196A1 (de)
PL (1) PL181437B1 (de)
PT (1) PT716852E (de)
RU (1) RU2150276C1 (de)
SI (1) SI0716852T1 (de)
TR (1) TR199501165A1 (de)
TW (1) TW492875B (de)
UA (1) UA34479C2 (de)
YU (1) YU60795A (de)
ZA (1) ZA956411B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69712332T2 (de) * 1996-02-29 2002-10-02 Fujisawa Pharmaceutical Co Beta-lactam-antibiotikum enthaltende tabletten und verfahren zu deren herstellung
AU1150799A (en) * 1997-10-10 1999-05-03 Yamanouchi Europe B.V. Oral compositions containing a cephalosporin antibiotic
BR9915835A (pt) * 1998-12-01 2001-08-21 Novo Nordisk As Composição farmacêutica, e, processo para a preparação de uma composição
DE10005017A1 (de) * 2000-02-04 2001-08-09 Cognis Deutschland Gmbh Duftstofftabletten
AU2002236166B2 (en) * 2001-05-01 2006-12-07 Pfizer Products Inc. Method for manufacturing a low dose pharmaceutical composition
US7151432B2 (en) 2001-09-19 2006-12-19 Immersion Corporation Circuit and method for a switch matrix and switch sensing
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
TW200404550A (en) * 2002-07-08 2004-04-01 Sankyo Co Cepharospolin formulation for oral use
JP4526247B2 (ja) * 2002-07-08 2010-08-18 第一三共株式会社 経口用セファロスポリン製剤
DK1732605T3 (da) 2004-03-29 2019-06-11 Wyeth Llc Multi-vitamin- og mineral-kosttilskud
US8968768B2 (en) * 2004-03-29 2015-03-03 Wyeth Llc Phytosterol nutritional supplements
EP1906937B1 (de) 2005-07-22 2016-10-19 Rubicon Research Pvt Ltd. Neuartige dispergierbare tabletten zusammensetzung
KR101465803B1 (ko) 2005-08-10 2014-11-26 시오노기세이야쿠가부시키가이샤 구강내 붕괴 정제
CN102579455B (zh) * 2012-03-19 2014-02-19 迪沙药业集团有限公司 一种稳定的头孢克洛咀嚼组合物
JP6841819B2 (ja) * 2015-09-14 2021-03-10 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 制御され、遅延された活性成分の放出を有する製剤
CN113750066B (zh) * 2021-10-12 2022-12-02 上海金城素智药业有限公司 一种具有临床优势的头孢克洛制剂及其制备方法和应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2259646C2 (de) * 1972-12-06 1984-11-22 Hoechst Ag, 6230 Frankfurt Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung
US3925372A (en) 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
YU36970B (en) 1973-02-23 1984-08-31 Lilly Co Eli Process for obtaining 7-(amino)-acylamido-3-halocephalosporins
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
GB2066662B (en) * 1979-12-21 1984-02-15 Glaxo Group Ltd Cephalexin powder compositions containing silicon dioxide
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
EP0181966A1 (de) * 1984-11-13 1986-05-28 Gist-Brocades N.V. Pressdragierte dispergierbare Tabletten
DE3887179T2 (de) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
DE3868245D1 (de) * 1987-11-30 1992-03-12 Gist Brocades Nv Pharmazeutische zusammensetzung und verfahren zu ihrer herstellung.
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
GB9009473D0 (en) * 1990-04-27 1990-06-20 Beecham Group Plc Pharmaceutical formulation
FR2669221B1 (fr) * 1990-11-15 1993-01-15 Rhone Poulenc Sante Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique.
EP0487774B1 (de) * 1990-11-29 1994-10-26 Wei Ming Pharmaceutical Mfg. Co. Ltd. Hilfsträger für direkte Verpressung
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
IT1251999B (it) * 1991-11-11 1995-05-27 Opos Biochimica Srl Forma cristallina di un antibiotico cefalosporinico
AU674516B2 (en) * 1992-04-30 1997-01-02 Schering Corporation Stable hydrated cephalosporin dry powder for oral suspension formulation
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
US5622719A (en) * 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US5616344A (en) * 1994-06-14 1997-04-01 Fuisz Technologies Ltd. Apparatus and process for strengthening low density compression dosage units and product therefrom
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin

Also Published As

Publication number Publication date
DE69521275T2 (de) 2001-10-31
CN1130506A (zh) 1996-09-11
JPH08208484A (ja) 1996-08-13
EP1086689A2 (de) 2001-03-28
FI953887A (fi) 1996-06-14
NO953192D0 (no) 1995-08-14
BR9504573A (pt) 1997-02-25
EP1086689A3 (de) 2001-07-11
KR100350565B1 (ko) 2003-02-05
TW492875B (en) 2002-07-01
CO4410176A1 (es) 1997-01-09
UA34479C2 (uk) 2001-03-15
NO953192L (no) 1996-06-14
ZA956411B (en) 1996-03-11
DK0716852T3 (da) 2001-09-03
IL114642A0 (en) 1995-11-27
FI953887A0 (fi) 1995-08-17
CN1136852C (zh) 2004-02-04
IL114642A (en) 1999-07-14
TR199501165A1 (tr) 1996-10-21
HUT73792A (en) 1996-09-30
PT716852E (pt) 2001-09-28
KR960021026A (ko) 1996-07-18
DE716852T1 (de) 1997-04-03
AU2509495A (en) 1996-06-20
NO309925B1 (no) 2001-04-23
PL309863A1 (en) 1996-06-24
HU9502160D0 (en) 1995-09-28
NZ272611A (en) 1997-08-22
RU2150276C1 (ru) 2000-06-10
US5861141A (en) 1999-01-19
EP0716852A1 (de) 1996-06-19
MY114687A (en) 2002-12-31
CA2158511A1 (en) 1996-06-14
GR3036503T3 (en) 2001-11-30
EP0716852B1 (de) 2001-06-13
ES2079327A1 (es) 1996-01-01
EP1086690A3 (de) 2001-07-11
PL181437B1 (pl) 2001-07-31
ES2091738T3 (es) 2001-08-16
ES2079327B1 (es) 1996-08-01
ATE201984T1 (de) 2001-06-15
SI0716852T1 (en) 2001-12-31
HK1012574A1 (en) 1999-08-06
AU702585B2 (en) 1999-02-25
ES2091738T1 (es) 1996-11-16
GR960300062T1 (en) 1996-11-30
CZ287248B6 (en) 2000-10-11
EP1086690A2 (de) 2001-03-28
CZ199895A3 (en) 1996-07-17
YU60795A (sh) 1998-07-10
PE5196A1 (es) 1996-03-26

Similar Documents

Publication Publication Date Title
ATE201984T1 (de) Pharmazeutische zubereitungen enthaltend cefaclor
NO952863L (no) Farmasöytiske preparater av fluoxetin
ATE232396T1 (de) Oxydiertes thymosin beta 4

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee